Search Results
Sep 11, 2025, 09:30 ET Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains
state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to identify
More news about: Co-Diagnostics
Sep 11, 2025, 09:17 ET Lucid Diagnostics Announces Closing of Public Offering of Common Stock
EsoGuard® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its
More news about: Lucid Diagnostics
Sep 11, 2025, 09:00 ET BetterMe Launches Corporate Wellness Program to Boost Global Workforce Productivity
organizations. "At BetterMe, we believe a healthy lifestyle must be accessible to everyone. This isn't just a business strategy but part of BetterMe's DNA. Real change comes from consistent choices in how we move, eat, and live," says Victoria Repa, CEO & Founder of BetterMe.
More news about: BetterMe
Sep 11, 2025, 08:35 ET Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
of epigenetic therapies that target dysregulated DNA methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury. Larsucosterol, DURECT's lead drug candidate, binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated
More news about: DURECT Corporation
Sep 11, 2025, 08:30 ET DNA-Encoded Library Data: Unlocking Chemomic Insights for Drug Discovery, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insight into why the majority of DNA-encoded library (DEL) data has historically been ignored, and what is being missed. Attendees will learn how chemomic approaches transform full DEL output into deep structure-activity relationship (SAR), structure-function maps and
More news about: Xtalks
Sep 11, 2025, 05:40 ET Global Pet Tech Market Poised to Surpass USD 23.8 Billion by 2030, According to Mordor Intelligence
https://www.mordorintelligence.com/industry-reports/veterinary-cardiology-market?utm_source=prnewswire Pet DNA Testing Market: The Pet DNA Testing Market Report is Segmented by Pet Type (Dogs, Cats, Other Companion Animals), Test Type (Breed Identification, Health Predisposition/Carrier
More news about: Mordor Intelligence Private Limited
Sep 10, 2025, 14:17 ET Fakulta Tongji SEM sa umiestnila celosvetovo na 8. mieste v rebríčku Master in Management podľa Financial Times za rok 2025
ŠANGHAJ, 10. september 2025 /PRNewswire/ – Dňa 8. septembra zverejnil denník Financial Times svoj globálny rebríček Master in Management za rok 2025. Fakulta ekonomiky a manažmentu Univerzity Tongji
More news about: Tongji University School of Economics and Management
Sep 10, 2025, 13:00 ET Rosalind Franklin University Names Aron Sousa, MD, FACP, as President and CEO
inquiry and excellence modeled by its namesake Dr. Rosalind Franklin, whose Photo 51 was crucial to solving the structure of DNA. Recognized for its research in areas including neuroscience, brain-related diseases, inherited disorders, diabetes, obesity, and gait and balance, RFU
More news about: Rosalind Franklin University of Medicine and Science
Sep 10, 2025, 12:09 ET Historic Camden and FHD Forensics Partner to Form Rev War Forensic Institute, Roll Out Early Findings
California-based ancient DNA experts, Astrea Forensics performed DNA extractions
More news about: Rev War Forensic Institute
Sep 10, 2025, 11:30 ET PLANESENSE CELEBRATES 30 YEARS OF INNOVATION IN PRIVATE AVIATION
and PC-24 jets in the United States. "As we celebrate this milestone, I am reminded that innovation is in our DNA," adds Antoniadis. "From pioneering new approaches for fractional ownership to embracing the latest advancements in aviation technology, we are constantly
More news about: PlaneSense
Sep 10, 2025, 11:00 ET Gozney Launches Dome Gen 2 Series, Their Biggest and Most Versatile Ovens Yet
simple. We build the highest-performing ovens out there. Every product we make comes from our engineering roots in commercial wood-fired ovens, and that DNA is what chefs trust." Available in Bone and Off Black colorways, the Dome Gen 2 Series reflects Gozney's commitment to elevated design, uncompromising
More news about: Gozney
Sep 10, 2025, 09:48 ET Israel Cancer Research Fund Surpasses $100 Million in Total Funding as New Grants Are Awarded
been awarded to ICRF-funded scientists for their innovative research, and past and present grantees have played key roles related to advancements in DNA methylation, BRCA, the RAD51 gene, novel bone marrow transplant technique, and much more. As Israel
More news about: Israel Cancer Research Fund
Sep 10, 2025, 09:00 ET THE NIKON ZR: A NEW ERA OF LIMITLESS CINEMATIC POSSIBILITIES, BORN FROM NIKON'S SYNERGY WITH RED DIGITAL CINEMA
Nikon Camera in the Z Cinema Series Combines Nikon's Optical expertise and High-Performance AF with RED's Color Science and Cinematic DNA MELVILLE, N.Y., Sept.
More news about: Nikon Inc.
Sep 10, 2025, 08:00 ET Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
EsoGuard® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its
More news about: Lucid Diagnostics
Sep 10, 2025, 07:19 ET Elisa DES is now Gridle - delivering energy flexibility services at scale
sites. After the service proved its value internally, Elisa commercialized it, and it has now been adopted by other telecom operators, such as Telenor's DNA Tower. Today, Gridle is a flexibility service for electricity markets that optimizes energy assets across multiple industries: from distributed batteries
More news about: Elisa Oyj
Sep 10, 2025, 06:45 ET Croma-Pharma GmbH Celebrates FDA Approval of Obagi saypha® MagIQ™ in the United States
brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand's distinct DNA. The first step in realizing its vision was the business combination with Obagi Medical and Milk Makeup. As part of the Waldencast platform, its brands
More news about: Croma Pharma
Sep 10, 2025, 06:00 ET Zillow brings AI-powered Virtual Staging to Showcase listings
vice president of AI at Zillow. "From the Zestimate to personalized search and now to dynamic listing experiences, AI has long been part of Zillow's DNA. Virtual Staging applies the AI field of computer vision to restyle listing photos in real time to help shoppers see a home's potential and give agents
More news about: Zillow
Sep 09, 2025, 16:36 ET WeRoad Launches Global Trade Partnership Programme Offering 300+ Group Adventures for Millennial and Gen Z Travellers
launched an international offering bringing together travellers from all over the world for English-speaking group adventures. It has a strong community DNA with a large social following (over 3.5 million followers). With the strength of its 3,000+ Coordinators, WeRoad has helped over 200,000 travellers
More news about: WeRoad
Sep 09, 2025, 16:01 ET Lucid Diagnostics Announces Proposed Public Offering of Common Stock
EsoGuard® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its
More news about: Lucid Diagnostics
![Partner Therapeutics Receives EMA Approval of IMREPLYS® (sargramostim, rhu GM-CSF) to Treat Exposure to Myelosuppressive Doses of Radiation (Hematopoietic Sub-syndrome of Acute Radiation Syndrome [H-ARS])](https://mma.prnewswire.com/media/633165/PTx_updated_logo.jpg?w=300){kind=logo}
Sep 09, 2025, 13:42 ET Partner Therapeutics Receives EMA Approval of IMREPLYS® (sargramostim, rhu GM-CSF) to Treat Exposure to Myelosuppressive Doses of Radiation (Hematopoietic Sub-syndrome of Acute Radiation Syndrome [H-ARS])
(SARGRAMOSTIM)5,6Sargramostim is a human granulocyte-macrophage colony-stimulating growth factor (GM-CSF) produced by recombinant DNA technology in a yeast (S. cerevisiae) expression system. The binding to GM-CSF receptors expressed on the surface of target cells (hematopoietic
More news about: Partner Therapeutics, Inc.
Sep 09, 2025, 12:00 ET Yellow Wood Partners Announces Sale of their Majority stake in skincare brand BYOMA
over 40 household global brands including Chapstick, Suave, Qtips, Caress, Ponds and Dr. Scholl's. The firm uses its differentiated Consumer Operating DNA® investment and operating strategy to partner with founders and CPG companies to unlock brand value, scale and grow their businesses. For more information,
More news about: Yellow Wood Partners
Sep 09, 2025, 12:00 ET Ayrton Senna captivates Gen Z: 6 in 10 young americans connect with the racing legend
legacy Ayrton Senna has transcended racing to become both a cultural icon and a contemporary brand that carries his DNA forward. Today, SENNA has a global portfolio of more than 65 partners and launches new product collections across diverse categories every year. The
More news about: Senna Brands
Sep 09, 2025, 10:30 ET SQAIRZ and Perfect Game Team Up for Limited Edition Palm Collab Baseball Shoe
cleat we've ever released," said Bob Winskowicz, Founder and CEO of SQAIRZ. "The Palm has the same performance DNA as our GFP™ line, but the design makes it stand out from anything else on the field. It's bold, it's fresh, and it turns heads—just like the players
More news about: SQAIRZ
Sep 09, 2025, 10:26 ET Maureen Power Sweeny Joins the Exceptional Women Alliance (EWA)
in scaling businesses through data-driven, technology-enabled growth strategies. She is the creator of The Growth Helix: Rewiring Organizational DNA to Align Strategy and Execution for C-Suite Success, a proprietary methodology that helps organizations unlock systemic growth. A collaborative,
More news about: Exceptional Women Alliance
Sep 09, 2025, 09:30 ET Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit
state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to identify
More news about: Co-Diagnostics